Endocrine-Related Cancer
Journal Impact IF - Analysis · Trend · Prediction · Ranking


New

Journal Impact IF

2019-2020

4.8

0.5%

Journal Impact IF Trend

Endocrine-Related Cancer

The 2019-2020 Journal Impact IF of Endocrine-Related Cancer is 4.8, which is just updated in 2020.

Highest IF
5.331
Highest Journal Impact IF

The highest Journal Impact IF of Endocrine-Related Cancer is 5.331.

Lowest IF
4.364
Lowest Journal Impact IF

The lowest Journal Impact IF of Endocrine-Related Cancer is 4.364.

Total Growth Rate
10.0%
IF Total Growth Rate

The total growth rate of Endocrine-Related Cancer IF is 10.0%.

Annual Growth Rate
1.1%
IF Annual Growth Rate

The annual growth rate of Endocrine-Related Cancer IF is 1.1%.

Journal Impact IF Ranking

Subcategory Quartile Rank Percentile
Oncology Q1 48/331

Oncology 85%

Cancer Research Q1 40/198

Cancer Research 80%

Endocrinology Q1 16/118

Endocrinology 86%

Endocrinology, Diabetes and Metabolism Q1 24/217

Endocrinology, Diabetes and Metabolism 89%

Journal Impact IF Ranking

· In the Oncology research field, the Quartile of Endocrine-Related Cancer is Q1. Endocrine-Related Cancer has been ranked #48 over 331 related journals in the Oncology research category. The ranking percentile of Endocrine-Related Cancer is around 85% in the field of Oncology.
· In the Cancer Research research field, the Quartile of Endocrine-Related Cancer is Q1. Endocrine-Related Cancer has been ranked #40 over 198 related journals in the Cancer Research research category. The ranking percentile of Endocrine-Related Cancer is around 80% in the field of Cancer Research.
· In the Endocrinology research field, the Quartile of Endocrine-Related Cancer is Q1. Endocrine-Related Cancer has been ranked #16 over 118 related journals in the Endocrinology research category. The ranking percentile of Endocrine-Related Cancer is around 86% in the field of Endocrinology.
· In the Endocrinology, Diabetes and Metabolism research field, the Quartile of Endocrine-Related Cancer is Q1. Endocrine-Related Cancer has been ranked #24 over 217 related journals in the Endocrinology, Diabetes and Metabolism research category. The ranking percentile of Endocrine-Related Cancer is around 89% in the field of Endocrinology, Diabetes and Metabolism.

Total Publications
2259
Total Citations
131921

Annual Publication Volume

Annual Citation Record

International Collaboration Trend

Cited Documents Trend

Journal Impact IF History

Year Journal Impact IF
Year Journal Impact IF
2019-2020 4.8
2018-2019 4.774
2017-2018 5.331
2016-2017 5.267
2015-2016 4.472
2014-2015 4.805
2013-2014 4.907
2012-2013 5.261
2011-2012 4.364
Journal Impact IF History

· The 2019-2020 Journal Impact IF of Endocrine-Related Cancer is 4.8
· The 2018-2019 Journal Impact IF of Endocrine-Related Cancer is 4.774
· The 2017-2018 Journal Impact IF of Endocrine-Related Cancer is 5.331
· The 2016-2017 Journal Impact IF of Endocrine-Related Cancer is 5.267
· The 2015-2016 Journal Impact IF of Endocrine-Related Cancer is 4.472
· The 2014-2015 Journal Impact IF of Endocrine-Related Cancer is 4.805
· The 2013-2014 Journal Impact IF of Endocrine-Related Cancer is 4.907
· The 2012-2013 Journal Impact IF of Endocrine-Related Cancer is 5.261
· The 2011-2012 Journal Impact IF of Endocrine-Related Cancer is 4.364

Publications Cites Dataset

Year Publications Citations
Year Publications Citations
1994 16 0
1995 30 15
1996 30 61
1997 49 54
1998 30 116
1999 59 213
2000 19 280
2001 29 674
2002 19 1212
2003 56 1612
2004 64 2079
2005 94 2704
2006 105 3823
2007 92 4622
2008 120 5672
2009 80 6192
2010 129 7335
2011 79 7939
2012 112 9219
2013 122 9686
2014 141 10162
2015 129 10077
2016 147 9853
2017 142 10072
2018 130 8392
2019 116 9041
2020 108 10112
2021 12 704
Publications Cites Dataset

· The Endocrine-Related Cancer has published 16 reports and received 0 citations in 1994.
· The Endocrine-Related Cancer has published 30 reports and received 15 citations in 1995.
· The Endocrine-Related Cancer has published 30 reports and received 61 citations in 1996.
· The Endocrine-Related Cancer has published 49 reports and received 54 citations in 1997.
· The Endocrine-Related Cancer has published 30 reports and received 116 citations in 1998.
· The Endocrine-Related Cancer has published 59 reports and received 213 citations in 1999.
· The Endocrine-Related Cancer has published 19 reports and received 280 citations in 2000.
· The Endocrine-Related Cancer has published 29 reports and received 674 citations in 2001.
· The Endocrine-Related Cancer has published 19 reports and received 1212 citations in 2002.
· The Endocrine-Related Cancer has published 56 reports and received 1612 citations in 2003.
· The Endocrine-Related Cancer has published 64 reports and received 2079 citations in 2004.
· The Endocrine-Related Cancer has published 94 reports and received 2704 citations in 2005.
· The Endocrine-Related Cancer has published 105 reports and received 3823 citations in 2006.
· The Endocrine-Related Cancer has published 92 reports and received 4622 citations in 2007.
· The Endocrine-Related Cancer has published 120 reports and received 5672 citations in 2008.
· The Endocrine-Related Cancer has published 80 reports and received 6192 citations in 2009.
· The Endocrine-Related Cancer has published 129 reports and received 7335 citations in 2010.
· The Endocrine-Related Cancer has published 79 reports and received 7939 citations in 2011.
· The Endocrine-Related Cancer has published 112 reports and received 9219 citations in 2012.
· The Endocrine-Related Cancer has published 122 reports and received 9686 citations in 2013.
· The Endocrine-Related Cancer has published 141 reports and received 10162 citations in 2014.
· The Endocrine-Related Cancer has published 129 reports and received 10077 citations in 2015.
· The Endocrine-Related Cancer has published 147 reports and received 9853 citations in 2016.
· The Endocrine-Related Cancer has published 142 reports and received 10072 citations in 2017.
· The Endocrine-Related Cancer has published 130 reports and received 8392 citations in 2018.
· The Endocrine-Related Cancer has published 116 reports and received 9041 citations in 2019.
· The Endocrine-Related Cancer has published 108 reports and received 10112 citations in 2020.
· The Endocrine-Related Cancer has published 12 reports and received 704 citations in 2021.
· The total publications of Endocrine-Related Cancer is 2259.
· The total citations of Endocrine-Related Cancer is 131921.

Endocrine-Related Cancer
Journal Profile
Endocrine-Related Cancer | Academic Accelerator - About the Journal

About

Endocrine-Related Cancer is an official flagship journal of the Society for Endocrinology and is endorsed by the European Society of Endocrinology, the United Kingdom and Ireland Neuroendocrine Society, and the Japanese Hormones and Cancer Society. Endocrine-Related Cancer provides a unique international forum for the publication of high quality original articles describing novel, cutting edge basic laboratory, translational and clinical investigations of human health and disease focusing on endocrine neoplasias and hormone-dependent cancers; and for the publication of authoritative review articles in these topics.Endocrine neoplasias include adrenal cortex, breast, multiple endocrine neoplasia, neuroendocrine tumours, ovary, prostate, paraganglioma, parathyroid, pheochromocytoma pituitary, testes, thyroid and hormone-dependent cancers. Neoplasias affecting metabolism and energy production such as bladder, bone, kidney, lung, and head and neck, are also considered. None

ISSN
1351-0088
ISSN

The ISSN of Endocrine-Related Cancer is 1351-0088 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

ISSN (Online)
-
ISSN (Online)

The ISSN (Online) of Endocrine-Related Cancer is - . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

Publisher
BioScientifica Ltd.
Publisher

Endocrine-Related Cancer is published by BioScientifica Ltd. .

Publication Frequency
Quarterly
Publication Frequency

Endocrine-Related Cancer publishes reports Quarterly .

Coverage
1994 - Present
Coverage

The Publication History of Endocrine-Related Cancer covers 1994 - Present .

Open Access
NO
Open Access

Endocrine-Related Cancer is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

Publication Fee
Review
Publication Fee

There is no publication fee for submiting manuscript to Endocrine-Related Cancer. Endocrine-Related Cancer is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.

Language
English
Language

The language of Endocrine-Related Cancer is English .

Country/Region
United Kingdom
Country/Region

The publisher of Endocrine-Related Cancer is BioScientifica Ltd. , which locates in United Kingdom .

Popular Journals

What is Impact Factor?

The impact factor (IF) is frequently used as an indicator of the importance of a journal to its field. It was first introduced by Eugene Garfield, the founder of the Institute for Scientific Information. Although IF is widely used by institutions and clinicians, people have widespread misconception regarding the method for calculating the journal IF, its significance and how it can be utilized. The IF of a journal is not associated to the factors like quality of peer review process and quality of content of the journal, but is a measure that reflects the average number of citations to articles published in journals, books, thesis, project reports, newspapers, conference/seminar proceedings, documents published in internet, notes, and any other approved documents.

Endocrine-Related Cancer | Academic Accelerator - About the Impact Factor

Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Journal Impact of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Journal Impact are often deemed to be more important than those with lower ones. The Endocrine-Related Cancer Journal Impact IF measures the average number of citations received in a particular year (2020) by papers published in the Endocrine-Related Cancer during the two preceding years (2018-2019). Note that 2020 Journal Impact are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. In addition to the 2-year Journal Impact, the 3-year Journal Impact can provide further insights and factors into the impact of Endocrine-Related Cancer.